NCLT Mumbai Validates Capital Reduction Over Buy-Back Under Section 66: An In-Depth Analysis of the Max India Limited Ruling

Corporate restructuring often requires companies to navigate complex statutory frameworks to optimize their capital structure. A recurring legal debate in this domain is the overlapping application of capital reduction provisions versus share buy-back mechanisms. The National Company Law Tribunal (NCLT), Mumbai Bench, recently delivered a crucial judgment in the matter of Max India Limited (Formerly Advaita Allied Health Services Limited), providing much-needed clarity on this subject.

The Tribunal sanctioned the assessee company's petition to reduce its equity share capital, dismissing objections that the transaction was merely a disguised buy-back. This comprehensive article delves into the factual background, procedural compliances, regulatory objections, and the ultimate judicial reasoning that shaped this landmark decision.

Factual Matrix of the Corporate Restructuring

The legal proceedings were initiated when the assessee company, Max India Limited, filed a petition under Section 66 of the Companies Act, 2013. The primary objective of this petition was to secure the Tribunal's confirmation for a special resolution aimed at reducing the company's equity share capital.

The Mechanics of the Proposed Reduction

The restructuring scheme proposed by the assessee company involved the following critical numerical parameters:

  • Maximum Shares to be Cancelled: Up to 1,07,57,252 equity shares.
  • Proportion of Capital: This represented approximately 20% of the company's total issued equity share capital.
  • Face Value: Each equity share carried a nominal value of ₹10.
  • Consideration Offered: The assessee company proposed a payout of ₹85 per share to the eligible public shareholders who voluntarily opted to surrender their holdings.
  • Maximum Cash Outflow: The total financial commitment for this exercise was capped at ₹91,43,66,420 (calculated as 1,07,57,252 shares multiplied by ₹85).

Rationale Behind the Capital Reduction

The foundational logic for this capital reduction traced back to a historical corporate commitment. In April 2019, the predecessor entity (erstwhile Max India Limited) declared its intention to utilize the financial proceeds generated from the divestment of its stake in Max Bupa Health Insurance Company Limited. The goal was twofold: to fuel future corporate expansion and to offer a lucrative exit route to existing shareholders who preferred not to remain invested during the company's next growth phase.

Following a composite scheme of arrangement approved by the NCLT in January 2020, the relevant business undertakings were demerged and vested into the current assessee company. To honor the earlier commitment, the current management initiated this optional capital reduction scheme.

Important Note: The promoter group explicitly submitted a confirmation stating they would abstain from participating in this capital reduction. This strategic withdrawal was designed to ensure that the maximum possible cash reserves remained available exclusively for the public shareholders seeking an exit.